Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-ALA patch (Alacare) PDT for actinic keratosis of the upper extremities
DRKS00015137Phase 2Completed
- Sponsor
- photonamic GmbH & Co. KG
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of 5-aminolevulinic acid in actinic keratosis (AK), sponsored by photonamic GmbH & Co. KG. Started Jul 2018; status: completed.
02
Drugs
5-aminolevulinic acid
03
Conditions
actinic keratosis (AK)
Beyond the preview
Go deeper on DRKS00015137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00015137.